^
    3years
    Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer. (PubMed, Anticancer Res)
    The cancer vaccine had positive effects on survival, indicating that this approach warrants further clinical studies.
    Clinical • Clinical Trial,Phase II • Journal
    |
    KDR (Kinase insert domain receptor) • VEGFA (Vascular endothelial growth factor A) • FLT1 (Fms-related tyrosine kinase 1)
    |
    OCV C01